HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
Objectives: This is a cross-sectional, observational study to determine the frequency and
associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse …
associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse …
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
Objective: While HIV-associated neurocognitive disorders (HAND) remain prevalent despite
combination antiretroviral therapy (CART), the clinical relevance of asymptomatic …
combination antiretroviral therapy (CART), the clinical relevance of asymptomatic …
Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study
Objective: To evaluate the frequency of HIV-associated neurocognitive disorder (HAND) in
HIV+ individuals and determine whether the frequency of HAND changed over 4 years of …
HIV+ individuals and determine whether the frequency of HAND changed over 4 years of …
[HTML][HTML] HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and
mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders …
mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders …
Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale
S Cross, N Önen, A Gase, ET Overton… - Journal of Neuroimmune …, 2013 - Springer
HIV-associated neurocognitive disorders (HAND) persist despite great advancements in
combination antiretroviral therapy (cART). The gold standard for diagnosing cognitive …
combination antiretroviral therapy (cART). The gold standard for diagnosing cognitive …
Global prevalence and burden of HIV-associated neurocognitive disorder: a meta-analysis
Objective To characterize the prevalence and burden of HIV-associated neurocognitive
disorder (HAND) and assess associated factors in the global population with HIV. Methods …
disorder (HAND) and assess associated factors in the global population with HIV. Methods …
Changing clinical phenotypes of HIV-associated neurocognitive disorders
N Sacktor - Journal of neurovirology, 2018 - Springer
HIV-associated neurocognitive disorder (HAND) remains a common cause of cognitive
impairment and persists in 15–55% of HIV+ individuals in the combination antiretroviral …
impairment and persists in 15–55% of HIV+ individuals in the combination antiretroviral …
HIV-associated neurological disorders: a guide to pharmacotherapy
IL Tan, JC McArthur - CNS drugs, 2012 - Springer
In the era of highly active antiretroviral therapy (HAART), HIV-1-associated neurocognitive
disorder (HAND) continues to be a common and significant morbidity among individuals …
disorder (HAND) continues to be a common and significant morbidity among individuals …
Updated research nosology for HIV-associated neurocognitive disorders
In 1991, the AIDS Task Force of the American Academy of Neurology published
nomenclature and research case definitions to guide the diagnosis of neurologic …
nomenclature and research case definitions to guide the diagnosis of neurologic …
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy
Objective: Despite immune recovery in individuals on combination antiretroviral therapy
(CART), the frequency of HIV-associated neurocognitive disorders (HANDs) remains high …
(CART), the frequency of HIV-associated neurocognitive disorders (HANDs) remains high …